Importance of Candida species other than C. albicans as pathogens in oncology patients.
暂无分享,去创建一个
[1] G. Tricot,et al. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. , 1987, Reviews of infectious diseases.
[2] J. O. Morrison,et al. Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity. , 1977, The Journal of infectious diseases.
[3] D. Fry,et al. Candida sepsis. Implications of polymicrobial blood-borne infection. , 1985, Archives of surgery.
[4] G. Hutchins,et al. Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii. , 1985, Annals of internal medicine.
[5] D. Louria,et al. The influence of cortisone on experimental fungus infections in mice. , 1960, The Journal of clinical investigation.
[6] A. Schaffner,et al. In vitro susceptibility of fungi to killing by neutrophil granulocytes discriminates between primary pathogenicity and opportunism. , 1986, The Journal of clinical investigation.
[7] G. Roberts,et al. Detection of yeasts and filamentous fungi in blood cultures during a 10-year period (1972 to 1981) , 1982, Journal of clinical microbiology.
[8] R. Coker,et al. Fluconazole and Candida krusei infections. , 1991, The Journal of hospital infection.
[9] M. J. Kennedy,et al. Effect of various antibiotics on gastrointestinal colonization and dissemination by Candida albicans. , 1985, Sabouraudia.
[10] A. Levine,et al. Fungemia with compromised host resistance. A study of 70 cases. , 1974, Annals of internal medicine.
[11] E. Law,et al. Speciation and amphotericin B sensitivity studies on blood isolates of Candida from burned patients , 1973, Journal of clinical pathology.
[12] W. Hughes. Systemic candidiasis: a study of 109 fatal cases. , 1982, Pediatric infectious disease.
[13] M. Phaneuf,et al. Gastrointestinal colonization and systemic dissemination by Candida albicans and Candida tropicalis in intact and immunocompromised mice , 1992, Infection and immunity.
[14] J. Burnie,et al. Assessment of DNA fingerprinting for rapid identification of outbreaks of systemic candidiasis. , 1989, BMJ.
[15] E. Seligmann. Virulence Enhancement of Candida albicans by Antibiotics and Cortisone , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[16] T. Abrahamsen,et al. Disseminated fungal disease resistant to fluconazole treatment in a child with leukemia. , 1992, Scandinavian journal of infectious diseases.
[17] C. Prober,et al. Prophylactic fluconazole and Candida krusei infections. , 1992, The New England journal of medicine.
[18] D. Armstrong,et al. Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. , 1981, The American journal of medicine.
[19] J. Wingard,et al. The value of fungal surveillance cultures as predictors of systemic fungal infections. , 1980, The Journal of infectious diseases.
[20] J. Wingard,et al. Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice , 1980, Infection and immunity.
[21] W. Merz,et al. Strain delineation and epidemiology of Candida (Clavispora) lusitaniae , 1992, Journal of clinical microbiology.
[22] W. Merz. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance , 1984, Journal of clinical microbiology.
[23] P. Spagnuolo,et al. Emergence of a new opportunistic pathogen, Candida lusitaniae , 1989, Journal of clinical microbiology.
[24] H. I. Winner,et al. The Pathogenicity of Candida Tropicalis. , 1962, Canadian Medical Association journal.
[25] H. Mobley,et al. The use of a DNA probe for epidemiological studies of candidiasis in immunocompromised hosts. , 1989, The Journal of infectious diseases.
[26] L. Friedman,et al. The effect of cortisone and antibiotic agents on experimental pulmonary aspergillosis. , 1959, The American journal of pathology.
[27] S. Solomon,et al. Outbreak of Candida parapsilosis endophthalmitis after cataract extraction and intraocular lens implantation , 1986, Journal of clinical microbiology.
[28] H. Lazarus,et al. Bacteremias and fungemias in oncologic patients with central venous catheters: changing spectrum of infection. , 1982, Archives of internal medicine.
[29] C. Verfaillie,et al. Candida infections in bone marrow transplant recipients. , 1991, Bone marrow transplantation.
[30] S. Solomon,et al. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers , 1987, Journal of clinical microbiology.
[31] B. Strom,et al. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. , 1989, The American journal of medicine.
[32] J. Myers,et al. Nosocomial fungemia in a large community teaching hospital. , 1987, Archives of internal medicine.
[33] D. Tyras,et al. Single-source outbreak of Candida tropicalis complicating coronary bypass surgery , 1989, Journal of clinical microbiology.
[34] J. Remington,et al. The compromised host and infection. II. Deep fungal infection. , 1969, The Journal of infectious diseases.
[35] E. Goldstein,et al. STUDIES ON THE PATHOGENESIS OF EXPERIMENTAL CANDIDA PARAPSILOSIS AND CANDIDA GUILLIERMONDII INFECTIONS IN MICE. , 1965, The Journal of infectious diseases.
[36] J. Karp,et al. Increased incidence of fungemia caused by Candida krusei , 1986, Journal of clinical microbiology.
[37] J. Sobel,et al. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. , 1993, The American journal of medicine.
[38] R. Torack. Fungus infections associated with antibiotic and steroid therapy. , 1957, The American journal of medicine.
[39] Y. S. Sathe,et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. , 1966, Annals of internal medicine.
[40] M. A. McIlroy. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia, and typhlitis. , 1991, The Journal of infectious diseases.
[41] A. Irvine,et al. Epidemic postsurgical Candida parapsilosis endophthalmitis. Clinical findings and management of 15 consecutive cases. , 1985, Ophthalmology.
[42] J. Wingard,et al. Candida tropicalis: a major pathogen in immunocompromised patients. , 1979, Annals of internal medicine.
[43] J. Aisner,et al. Torulopsis glabrata infections in patients with cancer. Increasing incidence and relationship to colonization. , 1976, The American journal of medicine.
[44] W. Powderly,et al. Amphotericin B-resistant yeast infection in severely immunocompromised patients. , 1988, The American journal of medicine.
[45] J. Gruhn,et al. Mycotic infections in leukemic patients at autopsy , 1963, Cancer.
[46] R. Myerowitz,et al. Disseminated candidiasis. Changes in incidence, underlying diseases, and pathology. , 1977, American journal of clinical pathology.
[47] B. Wong,et al. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. , 1985, Reviews of infectious diseases.
[48] Mankowski Zt,et al. Action of cortisone and ACTH on experimental fungus infections. , 1954 .
[49] F. Mandelli,et al. Candida colonization and systemic infection in neutropenic patients. A retrospective study , 1989, Cancer.
[50] M. Huppert,et al. PATHOGENESIS OF CANDIDA ALBICANS INFECTION FOLLOWING ANTIBIOTIC THERAPY II , 1955, Journal of bacteriology.
[51] T. Eilard. Isolation of fungi in blood cultures. A review of fungal infections in the western part of Sweden 1970-1982. , 1987, Scandinavian journal of infectious diseases.
[52] H. Horowitz,et al. Fluconazole Prophylaxis of Fungal Infections in Patients with Acute Leukemia: Results of a Randomized Placebo-Controlled, Double-Blind, Multicenter Trial , 1993, Annals of Internal Medicine.
[53] D. Longo,et al. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study. , 1991, Archives of internal medicine.
[54] T. Walsh,et al. Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. , 1986, American journal of clinical pathology.
[55] D. Armstrong,et al. The prevalence of yeasts in clinical specimens from cancer patients. , 1980, American journal of clinical pathology.
[56] G. Sandford,et al. Isolation and characterization of a polyene-resistant variant of Candida tropicalis , 1979, Journal of clinical microbiology.
[57] J. Wingard,et al. Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole. , 1987, The American journal of medicine.
[58] J. L. Goodman,et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.
[59] A. Kligman,et al. Antibiotics and Fungous Infections1 , 1952 .
[60] H. Hasenclever,et al. Pathogenicity of C. albicans and C. tropicalis. , 1961, Sabouraudia.
[61] C. Hill,et al. Risk factors for candidemia in cancer patients: a case-control study , 1988, Journal of clinical microbiology.
[62] D. Louria,et al. Disseminated moniliasis In the Adult. , 1962 .
[63] L. Zimmerman,et al. Fatal fungus infections complicating other diseases. , 1955, American journal of clinical pathology.
[64] B. Leventhal,et al. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[65] R. Guinet,et al. Fatal septicemia due to amphotericin B-resistant Candida lusitaniae , 1983, Journal of clinical microbiology.
[66] V. Andriole,et al. Factors Influencing Experimental Candidiasis in Mice. I. Alloxan Diabetes † , 1962, The Yale journal of biology and medicine.
[67] S. Thongprasert,et al. Systemic candidiasis in cancer patients. , 1984, The American journal of medicine.
[68] J. Plouffe,et al. Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. , 1977, Archives of internal medicine.
[69] M G Rinaldi,et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. , 1991, The New England journal of medicine.
[70] G. Finkel,et al. The pathogenesis of Candida tropicalis infections in mice. , 1966, Sabouraudia.
[71] D. Holzschu,et al. Identification of Candida lusitaniae as an opportunistic yeast in humans , 1979, Journal of clinical microbiology.